Document is current
Any future updates will be listed below
-
Authors
Thanarajasingam, Gita
Bhatnagar, Vishal
Noble, Brie N.
Chen, Ting-Yu
Fiero, Mallorie H.
Hoffman, Ron
Jeffery, Molly
Mazza, Gina L.
Mascarenhas, John
Mesa, Ruben
Murugappan, Meena
Ross, Joseph
Sidana, Surbhi
Warsame, Rahma
Kluetz, Paul G.
Dueck, Amylou C.
-
Funding
Funding for this research was provided by:
Oncology Center of Excellence, Food and Drug Administration (U01FD005938, U01FD005938, U01FD005938)
National Institutes of Health (P30CA015083, P01CA108671, P01CA108671, P01CA108671, P01CA108671)
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 18 June 2025
First Online: 7 August 2025
Declarations
:
: All trials were approved by institutional review boards or ethics committees at each site and written informed consent was obtained from all participants prior to enrollment. This study adhered to the ethical standards of the Declaration of Helsinki. The Mayo Clinic IRB deemed secondary analysis of clinical trial data and anonymous Zoom polling of stakeholder preferences as exempt (IRB# 22–010586).
: Not applicable.
: The authors declare no competing interests.
